Morlese J - Search Results

1

Diagnosis and management of male breast enlargement in patients with HIV/AIDS.

Qazi N, Morlese J, King DM, Ahmad R, Nelson M. Qazi N, et al. Among authors: morlese j. AIDS Read. 2000 Dec;10(12):703-8. AIDS Read. 2000. PMID: 11189741 Review.

2

Case report. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART.

Qazi NA, Morlese JF, Walsh JC, Bunker CB, Francis N, Nelson MR. Qazi NA, et al. AIDS Read. 2002 Oct;12(10):452-4, 456-7. AIDS Read. 2002. PMID: 12408103

3

True gynaecomastia, another manifestation of immune reconstitution disease?

Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR. Qazi NA, et al. Int J STD AIDS. 2002 Jan;13(1):59-65. doi: 10.1258/0956462021924514. Int J STD AIDS. 2002. PMID: 11802933 No abstract available.

4

Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis.

Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR. Qazi NA, et al. AIDS. 2002 Feb 15;16(3):506-7. doi: 10.1097/00002030-200202150-00033. AIDS. 2002. PMID: 11834973 No abstract available.

5

Lopinavir/ritonavir (ABT-378/r).

Qazi NA, Morlese JF, Pozniak AL. Qazi NA, et al. Expert Opin Pharmacother. 2002 Mar;3(3):315-27. doi: 10.1517/14656566.3.3.315. Expert Opin Pharmacother. 2002. PMID: 11866671 Review.

6

Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?

Morlese JF, Qazi NA, Gazzard BG, Nelson MR. Morlese JF, et al. AIDS. 2002 Sep 6;16(13):1840-1. doi: 10.1097/00002030-200209060-00023. AIDS. 2002. PMID: 12218402 No abstract available.

7

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection.

Morlese JF, Orkin CM, Abbas R, Burton C, Qazi NA, Nelson MR, Imami N, Gazzard BG. Morlese JF, et al. AIDS. 2003 Jun 13;17(9):1411-3. doi: 10.1097/00002030-200306130-00025. AIDS. 2003. PMID: 12799572 No abstract available.

8

The efficacy of lopinavir in individuals experiencing protease inhibitor failure.

Gilleece YC, Qazi NA, Morlese JF, Mandalia S, Gazzard BG, Pozniak AL, Nelson MR. Gilleece YC, et al. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):238-40. doi: 10.1097/00126334-200302010-00018. J Acquir Immune Defic Syndr. 2003. PMID: 12571536 Clinical Trial. No abstract available.

9

Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.

Ware LJ, Jackson AG, Wootton SA, Burdge GC, Morlese JF, Moyle GJ, Jackson AA, Gazzard BG. Ware LJ, et al. Among authors: morlese jf. Br J Nutr. 2009 Oct;102(7):1038-46. doi: 10.1017/S0007114509338817. Epub 2009 Jun 1. Br J Nutr. 2009. PMID: 19480729

10

Transferrin kinetics are altered in children with severe protein-energy malnutrition.

Morlese JF, Forrester T, Del Rosario M, Frazer M, Jahoor F. Morlese JF, et al. J Nutr. 1997 Aug;127(8):1469-74. doi: 10.1093/jn/127.8.1469. J Nutr. 1997. PMID: 9237939 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters